drugset / Trial / NCT02173899
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
716 enrolled
Changchun Keygen Biological Products Co., Ltd.
Guangdong Provincial Institute of Biological Products And Materia Medica · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to observe the occurrence of adverse events, seroconversion rate and geometric mean titres(GMTs) of 2 doses of live attenuated varicella vaccine.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varicella vaccine | Vaccine | 0.5 ml | — |